Acetylation of Tau Inhibits Its Degradation and Contributes to Tauopathy

@article{Min2010AcetylationOT,
  title={Acetylation of Tau Inhibits Its Degradation and Contributes to Tauopathy},
  author={Sang-Won Min and Seo-Hyun Cho and Yungui Zhou and Sebastian Schroeder and Vahram Haroutunian and William W. Seeley and Eric H. Huang and Yong Shen and Eliezer Masliah and Chandrani Mukherjee and David M Meyers and Philip A Cole and Melanie Ott and Li Gan},
  journal={Neuron},
  year={2010},
  volume={68}
}
Neurodegenerative tauopathies characterized by hyperphosphorylated tau include frontotemporal dementia and Parkinsonism linked to chromosome 17 (FTDP-17) and Alzheimer's disease (AD). Reducing tau levels improves cognitive function in mouse models of AD and FTDP-17, but the mechanisms regulating the turnover of pathogenic tau are unknown. We found that tau is acetylated and that tau acetylation prevents degradation of phosphorylated tau (p-tau). We generated two antibodies specific for… CONTINUE READING
Highly Influential
This paper has highly influenced 22 other papers. REVIEW HIGHLY INFLUENTIAL CITATIONS
231 Citations
53 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 231 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 53 references

Reisensburg Working Group for Tauopathies With Parkinsonism

  • A. C. Ludolph, J. Kassubek, +7 authors T Gasser
  • Eur. J. Neurol
  • 2009
1 Excerpt

Similar Papers

Loading similar papers…